Aarathi Nagaraja1, Paul Visintainer2, Janet P Haas3, Jonathan Menz4, Gary P Wormser1, Marisa A Montecalvo5. 1. Division of Infectious Diseases, Department of Medicine, New York Medical College, Valhalla, NY. 2. Tufts University School of Medicine, Division of Academic Affairs, Baystate Medical Center, Springfield, MA. 3. Division of Infectious Diseases, Department of Medicine, New York Medical College, Valhalla, NY; Department of Infection Prevention and Control, Westchester Medical Center, Valhalla, NY. 4. Department of Performance Management, Westchester Medical Center, Valhalla, NY. 5. Division of Infectious Diseases, Department of Medicine, New York Medical College, Valhalla, NY. Electronic address: marisa_montecalvo@nymc.edu.
Abstract
BACKGROUND: We previously reported a significant decrease in hospital-acquired (HA) Clostridium difficile infection (CDI) coincident with the introduction of pulsed xenon ultraviolet light for room disinfection (UVD). The purpose of this study was to evaluate CDI cases in greater detail to understand the effect of UVD. METHODS: CDI rates (HA and community acquired [CA]), CDI patient length of stay, room occupancy, and number of days between a CDI case in a room and an HA CDI case in the same room were studied for the first year of UVD compared with the 1-year period pre-UVD. RESULTS: Compared with pre-UVD, during UVD, HA CDI was 22% less (P = .06). There was a 70% decrease for the adult intensive care units (ICUs) (P < .001), where the percentage of room discharges with UVD was greater (P < .001). During UVD, CA CDI increased by 18%, and length of stay of all CDI cases was lower because of the greater proportion of CA CDI. No significant difference was found in days to HA CDI in rooms with a prior CDI occupant. CONCLUSION: These data suggest that UVD contributed to a reduction in ICU-acquired CDI where UVD was used for a larger proportion of discharges. Evaluation of UVD should include data for hospitalized CA CDI cases because these cases may impact the HA CDI rate.
BACKGROUND: We previously reported a significant decrease in hospital-acquired (HA) Clostridium difficileinfection (CDI) coincident with the introduction of pulsed xenon ultraviolet light for room disinfection (UVD). The purpose of this study was to evaluate CDI cases in greater detail to understand the effect of UVD. METHODS: CDI rates (HA and community acquired [CA]), CDI patient length of stay, room occupancy, and number of days between a CDI case in a room and an HA CDI case in the same room were studied for the first year of UVD compared with the 1-year period pre-UVD. RESULTS: Compared with pre-UVD, during UVD, HA CDI was 22% less (P = .06). There was a 70% decrease for the adult intensive care units (ICUs) (P < .001), where the percentage of room discharges with UVD was greater (P < .001). During UVD, CA CDI increased by 18%, and length of stay of all CDI cases was lower because of the greater proportion of CA CDI. No significant difference was found in days to HA CDI in rooms with a prior CDI occupant. CONCLUSION: These data suggest that UVD contributed to a reduction in ICU-acquired CDI where UVD was used for a larger proportion of discharges. Evaluation of UVD should include data for hospitalized CA CDI cases because these cases may impact the HA CDI rate.
Authors: L Clifford McDonald; Dale N Gerding; Stuart Johnson; Johan S Bakken; Karen C Carroll; Susan E Coffin; Erik R Dubberke; Kevin W Garey; Carolyn V Gould; Ciaran Kelly; Vivian Loo; Julia Shaklee Sammons; Thomas J Sandora; Mark H Wilcox Journal: Clin Infect Dis Date: 2018-03-19 Impact factor: 9.079
Authors: Deverick J Anderson; Luke F Chen; David J Weber; Rebekah W Moehring; Sarah S Lewis; Patricia F Triplett; Michael Blocker; Paul Becherer; J Conrad Schwab; Lauren P Knelson; Yuliya Lokhnygina; William A Rutala; Hajime Kanamori; Maria F Gergen; Daniel J Sexton Journal: Lancet Date: 2017-01-17 Impact factor: 79.321
Authors: Katherine Schultz; Emily Sickbert-Bennett; Ashley Marx; David J Weber; Lauren M DiBiase; Stacy Campbell-Bright; Lauren E Bode; Mike Baker; Tom Belhorn; Mark Buchanan; Sherie Goldbach; Jacci Harden; Emily Hoke; Beth Huenniger; Jonathan J Juliano; Michael Langston; Heather Ritchie; William A Rutala; Jason Smith; Shelley Summerlin-Long; Lisa Teal; Peter Gilligan Journal: J Clin Microbiol Date: 2018-08-27 Impact factor: 5.948
Authors: David J Weber; William A Rutala; Deverick J Anderson; Luke F Chen; Emily E Sickbert-Bennett; John M Boyce Journal: Am J Infect Control Date: 2016-05-02 Impact factor: 2.918